SENATO DELLA REPUBBLICA. DISEGNO DI LEGGE: Disposizioni per la prevenzione e la cura dell’obesità (n. 1483)
17 settembre 2025
Leggi
Breaking news
Glycaemic control and variability with different commercially available hybrid closed loop systems in people with type 1 diabetes: a systematic review and meta-analysis of randomized controlled trials
Di Molfetta S, Di Gioia L, Caruso I, et al.
Diabetes Obes Metab. Pub. online 29 Sep 2025.
Leggi
Relationship between TYG mediated pregnancy diabetes history and SII in American women: a retrospective cohort study of NHANES 2011-2018
Duan Y, Zhang R, Zhang Y, et al.
BMC Endocr Disord. Pub. online 22 Sep 2025.
Leggi
A real-world study comparing advanced hybrid closed-loop systems during pregnancy in women with type 1 diabetes
Quirós C, Wägner AM, Azriel S, et al.
Diabetes Technol Ther. Pub. online 26 Sep 2025.
Leggi
Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasis
Toledo FGS, Li Y, Wang F, et al.
Diabetologia. Pub. online 24 Sep 2025.
Leggi
Risk factors and adverse pregnancy outcomes associated with large for gestational age infants in pregnant women with type 2 diabetes mellitus
Yan X, Zhang L, Zheng W, et al.
BMC Pregnancy Childbirth. Pub. online 29 Sep 2025.
Leggi
GLP-1 receptor agonists and sarcopenia: weight loss at a cost? A brief narrative review
Pantazopoulos D, Gouveri E, Papazoglou D, Papanas N
Diabetes Res Clin Pract. Pub. online 27 Sep 2025.
Leggi
Tirzepatide and the 10-year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: a post hoc analysis from the three-year SURMOUNT-1 trial
Hankosky ER, Lebrec J, Lee CJ, et al.
Diabetes Obes Metab. Pub. online 29 Sep 2025.
Leggi
GLP-1 receptor agonists and cardiovascular outcomes in adults with diabetes and peripheral artery disease: an updated systematic review and meta-analysis
Shuja SH, Shuja MH, Shaukat A, et al.
Am J Cardiol. Pub. online 27 Sep 2025.
Leggi
UK best practice recommendations for children and young people <18 years with pre-stage 3 type 1 diabetes, on behalf of the British Society for Paediatric Endocrinology and Diabetes (BSPED)
Besser REJ, Campbell F, Damazer K
Diabet Med. 2025:e70117.
Leggi